Literature DB >> 30027626

Evaluation of Intratesticular Lesions With Strain Elastography Using Strain Ratio and Color Map Visual Grading: Differentiation of Neoplastic and Nonneoplastic Lesions.

Eleni Konstantatou1, Cheng Fang1, Odyssefs Romanos1, Lorenzo E Derchi2, Michele Bertolotto3, Massimo Valentino4, Christina Kalogeropoulou5, Paul S Sidhu1.   

Abstract

OBJECTIVE: To investigate the role of strain elastography using calculated strain ratio and visual elastography score in differentiating nonneoplastic, benign, and malignant neoplastic intratesticular lesions.
MATERIALS AND METHODS: The study was approved by the hospital review board as a retrospective review of 86 patients examined with gray scale, color Doppler ultrasonography and strain elastography (visual elastography score and strain ratio). Sensitivity, specificity, and positive and negative likelihood ratio of color Doppler and stain elastography were documented. Receiver operator characteristic curves assessed the diagnostic accuracy of strain elastography to discriminate nonneoplastic, benign, and malignant neoplasms. Histology or follow-up ultrasonography determined lesion character.
RESULTS: Thirty-one of 86 (36.0%) intratesticular malignant neoplasms, 17 of 86 (19.8%) benign neoplasms, and 38 of 86 (44.2%) nonneoplastic lesions were confirmed with histology (n = 52) or follow-up sonography (n = 34); 89.5% of intratesticular lesions were heterogeneous or hypoechoic on gray scale, with no difference between benign and malignant. Sensitivity, specificity, positive and negative likelihood ratio for nonneoplasm versus neoplasm were documented: color Doppler: 68.8%, 97.4%, 26.5, 0.32; visual elastography score: 81.3%, 57.9%, 1.93, 0.32; strain ratio: 68.8%, 81.6%, 3.73, 0.38. Neoplastic lesions showed a higher strain ratio than nonneoplastic lesions (P < .001), with strong correlation between median strain ratio and visual elastography score (Spearman's coefficient, 0.693; P < .001). Strain ratio is a significantly better assessment than visual elastography score for malignant lesions (P = .025). Logistic regression analysis revealed significant associations between size (P = .001), hypervascularity (P < .001), and malignancy.
CONCLUSION: Higher strain ratio and visual elastography score are associated with neoplastic lesions and offer an alternative to assess tissue characteristics but do not improve the diagnostic accuracy when compared with the color Doppler pattern.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  elastography; strain ratio; testicular neoplasm

Mesh:

Year:  2018        PMID: 30027626     DOI: 10.1002/jum.14686

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  4 in total

1.  Imaging in scrotal trauma: a European Society of Urogenital Radiology Scrotal and Penile Imaging Working Group (ESUR-SPIWG) position statement.

Authors:  Subramaniyan Ramanathan; Michele Bertolotto; Simon Freeman; Jane Belfield; Lorenzo E Derchi; Dean Y Huang; Francesco Lotti; Karolina Markiet; Olivera Nikolic; Parvati Ramchandani; Jonathan Richenberg; Laurence Rocher; Paul S Sidhu; Katarzyna Skrobisz; Athina Tsili; Pieter De Visschere; Irene Campo; Oliwia Kozak; Vikram Dogra
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

2.  Elastography of focal testicular lesions: current concepts and utility.

Authors:  Cheng Fang; Dean Y Huang; Paul S Sidhu
Journal:  Ultrasonography       Date:  2019-01-30

3.  Ultrasound Examination of Unilateral Seminoma in a Salernitano Stallion.

Authors:  Brunella Anna Giangaspero; Roberta Bucci; Francesca Del Signore; Massimo Vignoli; Jasmine Hattab; Gina Rosaria Quaglione; Lucio Petrizzi; Augusto Carluccio
Journal:  Animals (Basel)       Date:  2022-04-06       Impact factor: 2.752

Review 4.  Leydig Cell Tumors of the Testis: An Update of the Imaging Characteristics of a Not So Rare Lesion.

Authors:  Florian Maxwell; Alexia Savignac; Omar Bekdache; Sandra Calvez; Cédric Lebacle; Emmanuel Arama; Nada Garrouche; Laurence Rocher
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.